BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 21685475)

  • 1. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.
    Biddle A; Liang X; Gammon L; Fazil B; Harper LJ; Emich H; Costea DE; Mackenzie IC
    Cancer Res; 2011 Aug; 71(15):5317-26. PubMed ID: 21685475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors.
    Shigeishi H; Biddle A; Gammon L; Rodini CO; Yamasaki M; Seino S; Sugiyama M; Takechi M; Mackenzie IC
    J Oral Pathol Med; 2015 Mar; 44(3):201-7. PubMed ID: 25169655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.
    Biddle A; Gammon L; Liang X; Costea DE; Mackenzie IC
    EBioMedicine; 2016 Feb; 4():138-45. PubMed ID: 26981578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo characterization of cancer stem cell subpopulations in oral squamous cell carcinoma.
    Amôr NG; Buzo RF; Ortiz RC; Lopes NM; Saito LM; Mackenzie IC; Rodini CO
    J Oral Pathol Med; 2021 Jan; 50(1):52-59. PubMed ID: 32816395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
    Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
    Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.
    Xie G; Ji A; Yuan Q; Jin Z; Yuan Y; Ren C; Guo Z; Yao Q; Yang K; Lin X; Chen L
    Br J Cancer; 2014 May; 110(10):2514-23. PubMed ID: 24755887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphere-forming-like cells (squamospheres) with cancer stem-like cell traits from VX2 rabbit buccal squamous cell carcinoma.
    Chen YK; Huang AH; Lin LM
    Int J Oral Sci; 2014 Dec; 6(4):212-8. PubMed ID: 25012868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.
    Chen C; Wei Y; Hummel M; Hoffmann TK; Gross M; Kaufmann AM; Albers AE
    PLoS One; 2011 Jan; 6(1):e16466. PubMed ID: 21304586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.